Glenda Gray to Incidence
This is a "connection" page, showing publications Glenda Gray has written about Incidence.
Connection Strength
0,320
-
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infect Dis. 2014 May; 14(5):388-96.
Score: 0,096
-
Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine. Curr Opin HIV AIDS. 2010 Sep; 5(5):357-61.
Score: 0,076
-
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP Use. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):376-383.
Score: 0,041
-
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021 03 18; 384(11):1003-1014.
Score: 0,039
-
Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012. BMC Public Health. 2016 Apr 14; 16:330.
Score: 0,028
-
Does routine prophylactic oral flucloxacillin reduce the incidence of post-circumcision infections? Am J Infect Control. 2013 Oct; 41(10):897-900.
Score: 0,023
-
HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort. Int J Tuberc Lung Dis. 2009 Jul; 13(7):862-7.
Score: 0,017